Recap: Biomarin Pharmaceutical Q4 Earnings

Biomarin Pharmaceutical BMRN reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Biomarin Pharmaceutical reported in-line EPS of $-0.32 versus an estimate of $-0.32.

Revenue was up $2.31 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 9.04% increase in the share price the next day.

Here's a look at Biomarin Pharmaceutical's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.